natco pharma semaglutide gets CDSCO nod to manufacture and market generic injection in India. The drug is used to treat adults with inadequately controlled type 2 diabetes, alongside diet and exercise. #natcopharma # natco pharma semaglutide beats rivals
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12



























